US Patent Issued to NEW YORK GENOME CENTER, New York University on Nov. 4 for "Methods and compositions comprising CRISPR-Cpf1 and paired guide CRISPR RNAs for programmable genomic deletions" (New York Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,200, issued on Nov. 4, was assigned to NEW YORK GENOME CENTER INC. (New York) and New York University (New York).

"Methods and compositions comprising CRISPR-Cpf1 and paired guide CRISPR RNAs for programmable genomic deletions" was invented by Neville Espi Sanjana (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are methods comprises transducing a mammalian cell with one or more virus vectors. Each vector comprises a nucleic acid sequence encoding a Cpf1 (also known as Cas12a) protein and an optional selectable marker in operative association with an RNA pol II promoter which controls expression thereof, and a CRISPR RNA (crRNA) arr...